Shareholder Info

Share Price Information

ThromboGenics is listed on the Eurolist by Euronext Brussels under the symbol THR. Since 2009, ThromboGenics has been listed on the NEXT 150 Index, which comprises mid- to large-capitalization stocks on the Euronext exchange.

As of 29 March 2012, ThromboGenics has a total number of 35,691,432 outstanding shares and a total number of 888,250 outstanding warrants.

View Shareholder History of Capital

Paying Agent Services

KBC Bank is acting as paying agent. The paying agent will not charge shareholders with respect to payments of dividends, the exercise of subscription rights, and other events concerning Thrombogenics’ shares. Shareholders should inform themselves about the amounts that other financial intermediaries may charge in connection with paying agency services.